Connection

Vicente Boix to Anti-HIV Agents

Back to Details
This is a "connection" page, showing publications Vicente Boix has written about Anti-HIV Agents.
Vicente Boix
Connection Strength
0.269
Anti-HIV Agents
  1. Factors associated with the number of drugs in darunavir/cobicistat regimens. J Antimicrob Chemother. 2020 01 01; 75(1):208-214.
    View in: PubMed
    Score: 0.082
  2. Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study. PLoS One. 2018; 13(6):e0198768.
    View in: PubMed
    Score: 0.073
  3. Subclinical atherosclerosis in low Framingham risk HIV patients. Eur J Clin Invest. 2017 Aug; 47(8):591-599.
    View in: PubMed
    Score: 0.069
  4. Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis. Am J Trop Med Hyg. 2017 Oct; 97(4):1127-1133.
    View in: PubMed
    Score: 0.018
  5. Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016. Enferm Infecc Microbiol Clin. 2017 Jun - Jul; 35(6):377-383.
    View in: PubMed
    Score: 0.017
  6. The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males. J Sex Med. 2010 Aug; 7(8):2873-83.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.